Ocupress

Ocupress is a brand name of carteolol ophthalmic, approved by the FDA in the following formulation(s):

OCUPRESS (carteolol hydrochloride - solution/drops; ophthalmic)

• 
  Manufacturer: NOVARTIS
  
  Approval date: May 23, 1990
  
  Strength(s): 1% ^[RLD][AT]

Has a generic version of Ocupress been approved?

Yes. The following products are equivalent to Ocupress:

carteolol hydrochloride solution/drops; ophthalmic

• 
  Manufacturer: ALCON
  
  Approval date: January 3, 2000
  
  Strength(s): 1% ^[AT]


• 
  Manufacturer: BAUSCH AND LOMB
  
  Approval date: January 20, 2000
  
  Strength(s): 1% ^[AT]


• 
  Manufacturer: NOVEX
  
  Approval date: February 6, 2002
  
  Strength(s): 1% ^[AT]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ocupress. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Ocupress.

See also...

• Ocupress Consumer Information (Cerner Multum)
• Ocupress Advanced Consumer Information (Micromedex)
• Carteolol Drops Consumer Information (Wolters Kluwer)
• Carteolol ophthalmic Consumer Information (Cerner Multum)
• Carteolol Ophthalmic Advanced Consumer Information (Micromedex)